10 20 30 40 50 60 70 80 1OPT - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER PROTEIN BINDING/VIRUS/VIRAL PROTEIN/ 06-MAR-03 1OPT
TITLE THEORETICAL MODEL OF CCR5 RECEPTOR IN COMPLEX WITH HIV TITLE 2 GP120 ENVELOPE GLYCOPROTEIN AND CD4 RECEPTOR
COMPND MOL_ID: 1; COMPND 2 MOLECULE: C-C CHEMOKINE RECEPTOR TYPE 5; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CCR5; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: EXTERIOR MEMBRANE GLYCOPROTEIN; COMPND 7 CHAIN: G; COMPND 8 FRAGMENT: CORE; COMPND 9 SYNONYM: ENVELOPE GLYCOPROTEIN GP120; COMPND 10 MUTATION: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: T-CELL SURFACE GLYCOPROTEIN CD4; COMPND 13 CHAIN: C; COMPND 14 FRAGMENT: D1D2, N-TERMINAL TWO DOMAIN FRAGMENT
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 MOL_ID: 2; SOURCE 5 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; SOURCE 6 ORGANISM_COMMON: HIV-1; SOURCE 7 MOL_ID: 3; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN
KEYWDS GLYCOPROTEIN, G-PROTEIN COUPLED RECEPTOR, COMPLEX (HIV KEYWDS 2 ENVELOPE PROTEIN/CD4/CCR5)
EXPDTA THEORETICAL MODEL
AUTHOR S.Q.LIU,X.F.SHI,Z.R.SUN
REVDAT 1 25-MAR-03 1OPT 0
JRNL AUTH S.Q.LIU,X.F.SHI,Z.R.SUN JRNL TITL STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF JRNL TITL 2 HUMAN CCR5 RECEPTOR IN COMPLEX WITH HIV GP120 JRNL TITL 3 ENVELOPE GLYCOPROTEIN AND CD4 RECEPTOR BY JRNL TITL 4 MOLECULAR MODELING STUDIES JRNL REF TO BE PUBLISHED JRNL REFN
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.Q.LIU,X.F.SHI,Z.R.SUN REMARK 1 TITL CHARACTERIZE DYNAMIC CONFORMATIONAL SPACE OF HUMAN REMARK 1 TITL 2 CCR5 EXTRACELLULAR DOMAIN BY MOLECULAR MODELING REMARK 1 TITL 3 AND MOLECULAR DYNAMICS SIMULATION REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN
REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : INSIGHT II 2002 REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1OPT COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 12-MAR-2003. REMARK 100 THE RCSB ID CODE IS RCSB018542.
REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: THIS MODEL INDICATES THAT THE ECL2 OF CCR5 BEGINS TO REMARK 220 INTERACT WITH V3 LOOP BASE OF GP120, IT IS A SNAPSHOT OF REMARK 220 THE TRANSITION STATE OF THE BINDING OF CCR5 TO GP120. REMARK 220 THIS STRUCTURE WAS BUILT USING APPROACHES OF HOMOLOGY REMARK 220 MODELING AND DOCKING. THE STRUCTURES OF THE REMARK 220 TRANSMEMBRANE HELICES OF CCR5 WERE FIXED AND THE REMARK 220 CONFORMATION OF GP120-CD4 WAS TETHERED DURING MOLECULAR REMARK 220 DYNAMICS SIMULATION AND DOCKING.
REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS.
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER G 398 REMARK 465 THR G 399 REMARK 465 TRP G 400 REMARK 465 SER G 401 REMARK 465 THR G 402 REMARK 465 GLU G 403 REMARK 465 GLY G 404 REMARK 465 SER G 405 REMARK 465 ASN G 406 REMARK 465 ASN G 407 REMARK 465 THR G 408 REMARK 465 GLU G 409
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 11 98.37 148.71 REMARK 500 LYS A 59 -62.34 75.66 REMARK 500 VAL A 199 -85.29 78.40 REMARK 500 ARG A 225 -61.14 64.48 REMARK 500 ASN A 226 -59.50 75.53 REMARK 500 ARG A 235 -66.79 75.51 REMARK 500 GLN A 261 -70.02 64.07 REMARK 500 PHE A 264 -62.24 68.84 REMARK 500 ASP A 276 -63.06 84.52 REMARK 500 TYR A 307 -73.36 80.33 REMARK 500 GLN A 328 -85.99 59.57 REMARK 500 SER A 336 -72.03 71.23 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 MET A 1 ASP A 2 148.03 REMARK 500 ILE A 9 TYR A 10 -146.53 REMARK 500 CYS A 20 GLN A 21 139.63 REMARK 500 LYS A 22 ILE A 23 135.72 REMARK 500 ALA A 30 ARG A 31 -147.70 REMARK 500 MET A 100 CYS A 101 -82.98 REMARK 500 THR A 167 ARG A 168 -149.45 REMARK 500 PHE A 182 PRO A 183 143.18 REMARK 500 ILE A 198 VAL A 199 132.00 REMARK 500 PHE A 260 GLN A 261 141.72 REMARK 500 LEU A 266 ASN A 267 -143.07 REMARK 500 LEU A 275 ASP A 276 138.04 REMARK 500 GLN A 277 ALA A 278 -105.86
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1G9M RELATED DB: PDB REMARK 900 HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 REMARK 900 AND INDUCED NEUTRALIZING ANTIBODY 17B REMARK 900 RELATED ID: 1ND8 RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF HUMAN CCR5 WITH DISULFIDE BOND BETWEEN REMARK 900 CYS20 AND CYS269, THE N-TERMINUS 1-19 REGION OF THIS REMARK 900 STRUCTURE EXTENDS INTO THE OUTER SPACE OF THE DOMAIN FORMED REMARK 900 BY EXTRACELLULAR LOOP1-3. REMARK 900 RELATED ID: 1OPN RELATED DB: PDB REMARK 900 THE NT OF CCR5 RECOGNIZES AND BINDS TO BRIDGING SHEET OF REMARK 900 GP120 REMARK 900 RELATED ID: 1OPW RELATED DB: PDB REMARK 900 CCR5 FULLY INTERACTS WITH GP120
REMARK 999 REMARK 999 SEQUENCE REMARK 999 IN CHAIN G, GLY 128, ALA 129 AND GLY 194 SUBSTITUTE REMARK 999 FOR THE V1/V2 LOOP (128-194), GLY 298, ALA 299 AND REMARK 999 GLY 329 SUBSTITUTE FOR V3 LOOP (298-329).
DBREF 1OPT A 1 352 UNP P51681 CKR5_HUMAN 1 352 DBREF 1OPT G 83 127 UNP P04578 ENV_HV1H2 83 127 DBREF 1OPT G 195 297 UNP P04578 ENV_HV1H2 195 297 DBREF 1OPT G 330 492 UNP P04578 ENV_HV1H2 330 492 DBREF 1OPT C 1 181 UNP P01730 CD4_HUMAN 26 206
SEQADV 1OPT GLY G 128 UNP P04578 SEE REMARK 999 SEQADV 1OPT ALA G 129 UNP P04578 SEE REMARK 999 SEQADV 1OPT GLY G 194 UNP P04578 SEE REMARK 999 SEQADV 1OPT GLY G 298 UNP P04578 SEE REMARK 999 SEQADV 1OPT ALA G 299 UNP P04578 SEE REMARK 999 SEQADV 1OPT GLY G 329 UNP P04578 SEE REMARK 999
SEQRES 1 A 352 MET ASP TYR GLN VAL SER SER PRO ILE TYR ASP ILE ASN SEQRES 2 A 352 TYR TYR THR SER GLU PRO CYS GLN LYS ILE ASN VAL LYS SEQRES 3 A 352 GLN ILE ALA ALA ARG LEU LEU PRO PRO LEU TYR SER LEU SEQRES 4 A 352 VAL PHE ILE PHE GLY PHE VAL GLY ASN MET LEU VAL ILE SEQRES 5 A 352 LEU ILE LEU ILE ASN CYS LYS ARG LEU LYS SER MET THR SEQRES 6 A 352 ASP ILE TYR LEU LEU ASN LEU ALA ILE SER ASP LEU PHE SEQRES 7 A 352 PHE LEU LEU THR VAL PRO PHE TRP ALA HIS TYR ALA ALA SEQRES 8 A 352 ALA GLN TRP ASP PHE GLY ASN THR MET CYS GLN LEU LEU SEQRES 9 A 352 THR GLY LEU TYR PHE ILE GLY PHE PHE SER GLY ILE PHE SEQRES 10 A 352 PHE ILE ILE LEU LEU THR ILE ASP ARG TYR LEU ALA VAL SEQRES 11 A 352 VAL HIS ALA VAL PHE ALA LEU LYS ALA ARG THR VAL THR SEQRES 12 A 352 PHE GLY VAL VAL THR SER VAL ILE THR TRP VAL VAL ALA SEQRES 13 A 352 VAL PHE ALA SER LEU PRO GLY ILE ILE PHE THR ARG SER SEQRES 14 A 352 GLN LYS GLU GLY LEU HIS TYR THR CYS SER SER HIS PHE SEQRES 15 A 352 PRO TYR SER GLN TYR GLN PHE TRP LYS ASN PHE GLN THR SEQRES 16 A 352 LEU LYS ILE VAL ILE LEU GLY LEU VAL LEU PRO LEU LEU SEQRES 17 A 352 VAL MET VAL ILE CYS TYR SER GLY ILE LEU LYS THR LEU SEQRES 18 A 352 LEU ARG CYS ARG ASN GLU LYS LYS ARG HIS ARG ALA VAL SEQRES 19 A 352 ARG LEU ILE PHE THR ILE MET ILE VAL TYR PHE LEU PHE SEQRES 20 A 352 TRP ALA PRO TYR ASN ILE VAL LEU LEU LEU ASN THR PHE SEQRES 21 A 352 GLN GLU PHE PHE GLY LEU ASN ASN CYS SER SER SER ASN SEQRES 22 A 352 ARG LEU ASP GLN ALA MET GLN VAL THR GLU THR LEU GLY SEQRES 23 A 352 MET THR HIS CYS CYS ILE ASN PRO ILE ILE TYR ALA PHE SEQRES 24 A 352 VAL GLY GLU LYS PHE ARG ASN TYR LEU LEU VAL PHE PHE SEQRES 25 A 352 GLN LYS HIS ILE ALA LYS ARG PHE CYS LYS CYS CYS SER SEQRES 26 A 352 ILE PHE GLN GLN GLU ALA PRO GLU ARG ALA SER SER VAL SEQRES 27 A 352 TYR THR ARG SER THR GLY GLU GLN GLU ILE SER VAL GLY SEQRES 28 A 352 LEU SEQRES 1 G 317 GLU VAL VAL LEU VAL ASN VAL THR GLU ASN PHE ASN MET SEQRES 2 G 317 TRP LYS ASN ASP MET VAL GLU GLN MET HIS GLU ASP ILE SEQRES 3 G 317 ILE SER LEU TRP ASP GLN SER LEU LYS PRO CYS VAL LYS SEQRES 4 G 317 LEU THR PRO LEU CYS VAL GLY ALA GLY SER CYS ASN THR SEQRES 5 G 317 SER VAL ILE THR GLN ALA CYS PRO LYS VAL SER PHE GLU SEQRES 6 G 317 PRO ILE PRO ILE HIS TYR CYS ALA PRO ALA GLY PHE ALA SEQRES 7 G 317 ILE LEU LYS CYS ASN ASN LYS THR PHE ASN GLY THR GLY SEQRES 8 G 317 PRO CYS THR ASN VAL SER THR VAL GLN CYS THR HIS GLY SEQRES 9 G 317 ILE ARG PRO VAL VAL SER THR GLN LEU LEU LEU ASN GLY SEQRES 10 G 317 SER LEU ALA GLU GLU GLU VAL VAL ILE ARG SER VAL ASN SEQRES 11 G 317 PHE THR ASP ASN ALA LYS THR ILE ILE VAL GLN LEU ASN SEQRES 12 G 317 THR SER VAL GLU ILE ASN CYS THR GLY ALA GLY HIS CYS SEQRES 13 G 317 ASN ILE SER ARG ALA LYS TRP ASN ASN THR LEU LYS GLN SEQRES 14 G 317 ILE ALA SER LYS LEU ARG GLU GLN PHE GLY ASN ASN LYS SEQRES 15 G 317 THR ILE ILE PHE LYS GLN SER SER GLY GLY ASP PRO GLU SEQRES 16 G 317 ILE VAL THR HIS SER PHE ASN CYS GLY GLY GLU PHE PHE SEQRES 17 G 317 TYR CYS ASN SER THR GLN LEU PHE ASN SER THR TRP PHE SEQRES 18 G 317 ASN SER THR TRP SER THR GLU GLY SER ASN ASN THR GLU SEQRES 19 G 317 GLY SER ASP THR ILE THR LEU PRO CYS ARG ILE LYS GLN SEQRES 20 G 317 ILE ILE ASN MET TRP GLN LYS VAL GLY LYS ALA MET TYR SEQRES 21 G 317 ALA PRO PRO ILE SER GLY GLN ILE ARG CYS SER SER ASN SEQRES 22 G 317 ILE THR GLY LEU LEU LEU THR ARG ASP GLY GLY ASN SER SEQRES 23 G 317 ASN ASN GLU SER GLU ILE PHE ARG PRO GLY GLY GLY ASP SEQRES 24 G 317 MET ARG ASP ASN TRP ARG SER GLU LEU TYR LYS TYR LYS SEQRES 25 G 317 VAL VAL LYS ILE GLU SEQRES 1 C 181 LYS LYS VAL VAL LEU GLY LYS LYS GLY ASP THR VAL GLU SEQRES 2 C 181 LEU THR CYS THR ALA SER GLN LYS LYS SER ILE GLN PHE SEQRES 3 C 181 HIS TRP LYS ASN SER ASN GLN ILE LYS ILE LEU GLY ASN SEQRES 4 C 181 GLN GLY SER PHE LEU THR LYS GLY PRO SER LYS LEU ASN SEQRES 5 C 181 ASP ARG ALA ASP SER ARG ARG SER LEU TRP ASP GLN GLY SEQRES 6 C 181 ASN PHE PRO LEU ILE ILE LYS ASN LEU LYS ILE GLU ASP SEQRES 7 C 181 SER ASP THR TYR ILE CYS GLU VAL GLU ASP GLN LYS GLU SEQRES 8 C 181 GLU VAL GLN LEU LEU VAL PHE GLY LEU THR ALA ASN SER SEQRES 9 C 181 ASP THR HIS LEU LEU GLN GLY GLN SER LEU THR LEU THR SEQRES 10 C 181 LEU GLU SER PRO PRO GLY SER SER PRO SER VAL GLN CYS SEQRES 11 C 181 ARG SER PRO ARG GLY LYS ASN ILE GLN GLY GLY LYS THR SEQRES 12 C 181 LEU SER VAL SER GLN LEU GLU LEU GLN ASP SER GLY THR SEQRES 13 C 181 TRP THR CYS THR VAL LEU GLN ASN GLN LYS LYS VAL GLU SEQRES 14 C 181 PHE LYS ILE ASP ILE VAL VAL LEU ALA PHE GLN LYS
HELIX 1 1 LEU A 32 CYS A 58 1 27 HELIX 2 2 TYR A 68 VAL A 83 1 16 HELIX 3 3 VAL A 83 ALA A 91 1 9 HELIX 4 4 LEU A 103 PHE A 109 1 7 HELIX 5 5 ILE A 110 ILE A 124 1 15 HELIX 6 6 ILE A 151 LEU A 161 1 11 HELIX 7 7 VAL A 199 LEU A 205 1 7 HELIX 8 8 LEU A 207 ILE A 217 1 11 HELIX 9 9 ARG A 235 PHE A 260 1 26 HELIX 10 10 ALA A 278 MET A 287 1 10 HELIX 11 11 THR A 288 CYS A 290 5 3 HELIX 12 12 CYS A 291 VAL A 300 1 10 HELIX 13 13 ASN G 98 GLN G 114 1 17 HELIX 14 14 ARG G 335 PHE G 353 1 19 HELIX 15 15 ASP G 368 THR G 373 1 6 HELIX 16 16 SER G 387 PHE G 391 5 5 HELIX 17 17 ASP G 474 TYR G 484 1 11 HELIX 18 18 LEU C 51 ASP C 53 5 3 HELIX 19 19 ARG C 58 GLY C 65 5 8 HELIX 20 20 LYS C 75 SER C 79 5 5 HELIX 21 21 GLU C 150 SER C 154 5 5
SHEET 1 A 4 VAL G 84 PHE G 93 0 SHEET 2 A 4 GLY G 237 VAL G 245 -1 O GLY G 237 N PHE G 93 SHEET 3 A 4 PHE G 223 CYS G 228 -1 O ILE G 225 N VAL G 245 SHEET 4 A 4 TYR G 486 LYS G 490 -1 O LYS G 487 N LEU G 226 SHEET 1 B 4 SER G 199 ILE G 201 0 SHEET 2 B 4 VAL G 120 THR G 123 -1 O LYS G 121 N ILE G 201 SHEET 3 B 4 LYS G 432 MET G 434 -1 O LYS G 432 N LEU G 122 SHEET 4 B 4 ILE G 423 ASN G 425 -1 N ILE G 424 O ALA G 433 SHEET 1 C11 SER G 393 TRP G 395 0 SHEET 2 C11 ILE G 359 PHE G 361 -1 O ILE G 359 N TRP G 395 SHEET 3 C11 GLU G 466 PRO G 470 1 O GLU G 466 N ILE G 360 SHEET 4 C11 ARG G 444 ARG G 456 -1 O THR G 455 N ARG G 469 SHEET 5 C11 LEU G 260 LEU G 261 -1 O LEU G 260 N THR G 450 SHEET 6 C11 ARG G 444 ARG G 456 -1 N THR G 450 O LEU G 260 SHEET 7 C11 ILE G 284 THR G 297 -1 N ILE G 284 O LEU G 454 SHEET 8 C11 VAL G 271 ARG G 273 -1 O VAL G 271 N GLN G 287 SHEET 9 C11 ILE G 284 THR G 297 -1 N ILE G 285 O ARG G 273 SHEET 10 C11 HIS G 330 SER G 334 -1 O HIS G 330 N THR G 297 SHEET 11 C11 THR G 413 PRO G 417 -1 N ILE G 414 O ILE G 333 SHEET 1 D 3 HIS G 374 CYS G 378 0 SHEET 2 D 3 GLU G 381 CYS G 385 -1 N GLU G 381 O CYS G 378 SHEET 3 D 3 ILE G 420 LYS G 421 -1 N LYS G 421 O PHE G 382 SHEET 1 E 9 PHE C 43 LYS C 46 0 SHEET 2 E 9 LYS C 35 GLN C 40 -1 O GLY C 38 N THR C 45 SHEET 3 E 9 PHE C 26 LYS C 29 -1 O PHE C 26 N ASN C 39 SHEET 4 E 9 THR C 81 VAL C 86 -1 N ILE C 83 O LYS C 29 SHEET 5 E 9 GLU C 91 ALA C 102 -1 N GLU C 91 O CYS C 84 SHEET 6 E 9 VAL C 3 LYS C 7 1 N VAL C 4 O GLN C 94 SHEET 7 E 9 GLU C 91 ALA C 102 1 O GLN C 94 N VAL C 4 SHEET 8 E 9 LEU C 114 GLU C 119 -1 N THR C 117 O THR C 101 SHEET 9 E 9 THR C 143 VAL C 146 -1 O LEU C 144 N LEU C 116 SHEET 1 F 3 VAL C 12 LEU C 14 0 SHEET 2 F 3 LEU C 69 ILE C 71 -1 N LEU C 69 O LEU C 14 SHEET 3 F 3 ALA C 55 ASP C 56 -1 O ASP C 56 N ILE C 70 SHEET 1 G 5 HIS C 107 LEU C 109 0 SHEET 2 G 5 LYS C 166 LEU C 177 1 O VAL C 175 N LEU C 108 SHEET 3 G 5 GLY C 155 GLN C 163 -1 N GLY C 155 O ILE C 174 SHEET 4 G 5 SER C 127 ARG C 131 -1 N SER C 127 O LEU C 162 SHEET 5 G 5 ASN C 137 GLY C 140 -1 N ILE C 138 O CYS C 130
SSBOND 1 CYS A 20 CYS A 269 SSBOND 2 CYS A 101 CYS A 178 SSBOND 3 CYS G 119 CYS G 205 SSBOND 4 CYS G 126 CYS G 196 SSBOND 5 CYS G 218 CYS G 247 SSBOND 6 CYS G 228 CYS G 239 SSBOND 7 CYS G 296 CYS G 331 SSBOND 8 CYS G 378 CYS G 445 SSBOND 9 CYS G 385 CYS G 418 SSBOND 10 CYS C 16 CYS C 84 SSBOND 11 CYS C 130 CYS C 159
CISPEP 1 TYR A 3 GLN A 4 0 12.85 CISPEP 2 ASP A 11 ILE A 12 0 -20.46 CISPEP 3 SER A 17 GLU A 18 0 3.93 CISPEP 4 PRO A 19 CYS A 20 0 10.26 CISPEP 5 ALA A 92 GLN A 93 0 -7.25 CISPEP 6 GLN A 93 TRP A 94 0 -2.01 CISPEP 7 PHE A 96 GLY A 97 0 -1.92 CISPEP 8 CYS A 101 GLN A 102 0 -1.48 CISPEP 9 TYR A 127 LEU A 128 0 1.53 CISPEP 10 ALA A 129 VAL A 130 0 4.55 CISPEP 11 PHE A 144 GLY A 145 0 -8.34 CISPEP 12 PHE A 166 THR A 167 0 -18.88 CISPEP 13 GLU A 172 GLY A 173 0 -0.25 CISPEP 14 GLN A 186 TYR A 187 0 -9.13 CISPEP 15 ARG A 223 CYS A 224 0 -12.89 CISPEP 16 ASN A 268 CYS A 269 0 0.72 CISPEP 17 GLY A 301 GLU A 302 0 3.76 CISPEP 18 ALA A 317 LYS A 318 0 -7.97 CISPEP 19 ALA A 331 PRO A 332 0 5.02 CISPEP 20 VAL A 338 TYR A 339 0 18.79 CISPEP 21 VAL A 350 GLY A 351 0 11.38
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000